AzTrials
AzTrials

Carpal Tunnel SyndromeNCT04453462

Efficacy of Local Direct Median Nerve Block

A study testing Endoscopic carpal tunnel release under local direct median nerve block and Endoscopic carpal tunnel release under brachial plexus block in people with Carpal Tunnel Syndrome and Anesthesia, Local, run by Thammasat University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Carpal tunnel syndrome is the most common compressive neuropathy. Carpal tunnel release is indicated when failed conservative treatment. Although it can be done either with local anesthesia or brachial plexus block, there is no gold standard of anesthetic choice. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Carpal Tunnel Syndrome, Anesthesia, Local
What is being tested?
Endoscopic carpal tunnel release under local direct median nerve block and Endoscopic carpal tunnel release under brachial plexus block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteThailand
Study dates
1 May 2018to 1 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient with carpal tunnel syndrome, confirmed by EMG
  • Failed conservative treatment 3 months
  • Age ≥18 years old

Who cannot join

  • Allergic history of xylocaine
  • Any other condition that can cause carpal tunnel syndrome or peripheral neuropathy e.g. DM, hypothyroidism, pregnancy, tumor
  • Any patient that has been coverted to open carpal tunnel release

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Thammasat University hospital

    Khlong Luang, Changwat Pathum Thani, 12120

Other trials in Thailand

About this study

Official title: Efficacy of Local Direct Median Nerve Block VS Brachial Plexus Block in Endoscopic Carpal Tunnel Release

Carpal tunnel syndrome is the most common compressive neuropathy. Carpal tunnel release is indicated when failed conservative treatment. Although it can be done either with local anesthesia or brachial plexus block, there is no gold standard of anesthetic choice. The study is conducted to compare the efficacy of two methods and we hypothesized that the local direct median nerve block has effectiveness in intraoperative pain control not inferior to brachial plexus block in endoscopic carpal tunnel release.

Read the detailed description

The study is randomized-control trial conducted in single center (Orthopaedic department, Faculty of medicine, Thammasat university) The patients with failed conservative treatment of carpal tunnel syndrome confirmed by EMG are enrolled and ramdomized with computerized block-of-4 method.The local direct median nerve block is done by the surgeon and brachial plexus block in done by single anesthesiologist after that the patient will be operated with 1-portal endoscopic carpal tunnel release (Agee technque) by single surgeon. Immediate postoperative the blinded observer will ask the patient about interaoperative pain in visual analog scale then the pateint is asked to record the 2-hr, 4-hr ,6-hr and 12-hr postoperative pain in case record form.The patient will return the case record form at 2-week and also stitched off the wound then next follow up will be 4, 12, 24 weeks to assess functional outcome (Thai version Bonton questionaire)

Being tested
Endoscopic carpal tunnel release under local direct median nerve block, Endoscopic carpal tunnel release under brachial plexus block
Keywords
Endoscopic carpal tunnel release
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopic carpal tunnel release under local direct median nerve blockProcedure or surgery

    local direct median nerve block is performed by surgeon using the 1%xylocaine with adrenaline 12 mL(5 mL subcutaneous at incision site and 7 mL over median nerve) (maximum dose 7 mg/kg) before the endoscopic carpal tunnel release(1-portal Agee technique)

  • Endoscopic carpal tunnel release under brachial plexus blockProcedure or surgery

    brachial plexus block under ultrasound-guided is performed by experienced single anesthesiologist using the 1%xylocaine with adrenaline 15 mL (maximum dose 7 mg/kg) before the endoscopic carpal tunnel release(1-portal Agee technique)

Study groups in NCT04453462
Study groupRoleWhat they receive
Local direct median nerve blockActive comparatorThe local anesthetic technique is proposed by Wood SH and Logan AM in 1999 by using the plastic catheter to inject the anesthetic 4 cm proximally to the incision site direct over the median and ulna nerve
Receives: Procedure: Endoscopic carpal tunnel release under local direct median nerve block
Brachial plexus blockActive comparatorThe brachial plexus block technique is axillary block performed under ultrasound-guided by the well-trained anesthesiologist.
Receives: Procedure: Endoscopic carpal tunnel release under brachial plexus block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intraoperative pain measured as visual analog scale (VAS)

    Visual analog scale (VAS) from 0-10 0 means no pain 5 means moderate pain 10 means worst possible pain

    Immediate postoperative the blinded observer will ask the patient about interaoperative pain in visual analog scale

    Measured: Immediate postoperative period

Secondary outcomes (2)
  1. Postoperative pain measured as visual analog scale (VAS)

    Visual analog scale (VAS) from 0-10 0 means no pain 5 means moderate pain 10 means worst possible pain

    The pateint is asked to record the 2 hours, 4 hours, 6 hours and 12 hours postoperative pain in case record form.

    Measured: 2 hours, 4 hours, 6 hours and 12 hours postoperative period

  2. Functional outcome of the hand measured as Thai Version Boston Questionnaire

    There are 2 parts of Thai Version Boston Questionnaire

    1. Symptom severity scores (SSS) 11 items (total score 0-55; hign score means worse outcome)
    2. Functional severity scores (FSS) 8 items (total score 0-40; hign score means worse outcome)

    The follow up will be 1, 4, 12, 24 weeks to assess functional outcome with Thai Version Boston Questionnaire

    Measured: 2, 4, 12, 24 weeks postoperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2020
  2. Study start1 May 2018
  3. Primary completion1 Feb 2021
  4. Study completion1 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04453462
Sponsor's protocol ID
MTU-EC-OT-6-227/61
Status last verified
Apr 2023
First submitted
26 Jun 2020
Last updated
3 May 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Endoscopic carpal tunnel release under local direct median nerve block and Endoscopic carpal tunnel release under brachial plexus block in people with Carpal Tunnel Syndrome and Anesthesia, Local, run by Thammasat University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intraoperative pain measured as visual analog scale (VAS) (time frame: Immediate postoperative period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in